ENVERIC BIOSCIENCES INC (ENVB)
US29405E2081 - Common Stock
What's going on in today's after hours session
These stocks are moving in today's after hours session
Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results
Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002
Enveric Biosciences Announces Broad Range of Patent Issuances
Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003
Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop
Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit
Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q2 2024
ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enveric Biosciences (NASDAQ:ENVB) just reported results for the second quarter ...
Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results
Why Is Imunon (IMNN) Stock Up 259% Today?
Imunon stock is up on Tuesday with heavy trading of IMNN shares after posting positive results from a Phase 2 clinical trial.
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
Ekso Bionics stock is down on Tuesday as investors in the company react to its lackluster earnings report for the second quarter of the year.
Why Is Enveric Biosciences (ENVB) Stock Up 18% Today?
Enveric Biosciences stock is up on Tuesday with heavy trading of ENVB shares despite a lack of news from the company this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
Enveric Biosciences Announces Patent Granted for Drug Candidate
Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
Enveric Biosciences to Participate in BIO International Convention 2024
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enveric Biosciences (NASDAQ:ENVB) just reported results for the first quarter o...